NCT02033291View on ClinicalTrials.gov

Blood-brain Barrier Quantification in Cerebral Small Vessel Disease

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

October 31, 2016

Conditions
Blood-Brain Barrier PermeabilityCerebral Small Vessel DiseaseCerebral HemorrhageCortical Stroke
Interventions
PROCEDURE

Dynamic contrast enhanced Brain MRI

DCE-MRI is used to quantify the BBB permeability

Trial Locations (1)

5800

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT02033291 - Blood-brain Barrier Quantification in Cerebral Small Vessel Disease | Biotech Hunter | Biotech Hunter